India's NPPA Mulls Setting Price Parity For MNC Branded, Local Drugs
This article was originally published in PharmAsia News
Executive Summary
India's pricing authority reportedly is considering a move to require the prices for branded products to be based on their cost of production as a way of establishing parity to locally produced versions.